Restart Life Sciences Corp.
NMLSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,653 | $2,261 | $2 | $659 |
| - Cash | $87 | $165 | $243 | $11 |
| + Debt | $0 | $0 | $0 | $80 |
| Enterprise Value | $2,566 | $2,096 | -$241 | $728 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$171 | -$162 | -$685 | -$298 |
| % Margin | – | – | – | – |
| Net Income | -$211 | -$203 | -$819 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.01 | -0.01 | -30.63 | -0.001 |
| % Growth | 0% | 100% | -4,375,614.3% | – |
| Operating Cash Flow | – | -$78 | -$235 | -$11 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$78 | -$235 | -$11 |